1. Adrenergic bronchodilators mimic the actions of:
      A. Acetylcholine
      B. Penicillin
      C. Epinephrine
      D. norepinephrine

 

    1. Relaxation of smooth airway muscle in the presence of reversible airflow obstruction is a general indication for the use of:
      A. adrenergic bronchodilators
      B. antiinfective agents
      C. steroids
      D. mucolytics

 

    1. Disease states that could benefit from the use of adrenergic bronchodilators include which of the following?
      I. asthma
      II. bronchitis
      III. emphysema
      IV. bronchiectasis
      V. pleural effusionA. II, IV, and V only
      B. I, II, II, and IV only
      C. I, II, III, IV, and V
      D. I and III only

 

    1. Short-acting B2 agonists are indicated for:
      A. relief of acute reversible airflow obstruction
      B. maintenance of bronchodilation
      C. thinning of secretions
      D. reduction of airway edema

 

    1. Your patient is diagnosed with persistent asthma. Which type of drug would you recommend for maintenance bronchodilation and control of bronchospasm?
      A. long-acting adrenergic agent
      B. alpha-adrenergic agent
      C. mucolytic agent
      D. short-acting adrenergic agent

 

    1. Your patient presents with postextubation stridor. You recommend racemic epinephrine for its:
      A. short-acting B2-adrenergic effect
      B. long-acting B2-adrenergic effect
      C. B1-adrenergic effect
      D. alpha-adrenergic vasoconstricting effect

 

    1. You enter the room of a 2-year-old patient who presents with the characteristic “barking cough” found with croup. Once the diagnosis is confirmed, you may recommend which of the following medications to help provide relief from subglottic swelling?
      A. terbutaline
      B. racemic epinephrine
      C. salmeterol
      D. albuterol

 

    1. In a patient who is receiving large doses of catecholamines, you may expect to see all of the following side effects except:
      A. relaxation of brochial smooth muscle
      B. diuresis
      C. tachycardia
      D. incr blood pressure

 

    1. Levalbuterol is:
      A. the single (R)-isomer of albuterol
      B. an equal mixture of (R)- and (S)-isomers
      C. the same as racemic epinephrine
      D. the same as albuterol.

 

    1. Ephinephrine stimulates which sites?
      I. Alpha
      II. B1
      III. B2
      IV. CholinergicA. IV only
      B. I, II, and III only
      C. II, III, and IV only
      D. II only

 

    1. Epinephrine would be indicated for all of the following except:
      A. systemic hypersensitivity reactions
      B. acute asthma episodes
      C. cardiac stimulation
      D. treatment of infections

 

    1. Racemic epinephrine comes in what percent solution?
      A. 1.25%
      B. 2.25%
      C. 5.0%
      D. 0.05%

 

    1. The keyhole theory indicates that the larger the side-chain attachment to a catechol base, the:
      A. more easily it is metabolized
      B. more easily it is broken down by COMT
      C. greater B2 specificity
      D. shorter the duration of action

 

    1. Catecholamines are inactivated by:
      A. COMT
      B. ephinephrine
      C. ATP
      D. ACTH

 

    1. Catecholamines should not be given by which of the following routes:
      A. subcutaneous
      B. oral
      C. injection
      D. inhalation

 

    1. Albuterol is available in which of the following forms?
      I. syrup
      II. nebulizer solution
      III. MDI
      IV. oral tablets
      V. DPIA.I, II, and V only
      B. III, IV, and V only
      C. I, II, III, IV and V
      D. II and III only

 

    1. Salmeterol is:
      A. another name for albuterol
      B. available in nebulizer solution only
      C. a long-acting B-adrenergic
      c. indicated for acute asthma attacks

 

    1. Long-acting B2 agonists are indicated for:
      A. mucus reduction
      B. treating infections
      C. maintenance therapy for asthmatics
      D. acute asthma attacks

 

    1. The bronchodilating action of adrenergic drugs is due to stimulation of:
      A. cholinergic receptors
      B. B1 receptors
      C. B2 receptors
      D. alpha receptors

 

    1. B1 receptor stimulation will:
      A. provide upper airway decongestion
      B. incr heart rate and contractile force
      C. relax bronchiole smooth muscles
      D. cause vasoconstriction

 

    1. Smooth muscle relaxation most likely occurs as a result of:
      A. an incr in intracellular cAMP
      B. an incr in ATP
      C. a decr in ATP
      D. a decr in intracellular cAMP

 

    1. Inhalation is the preferred route of administering catecholamines for which of the following reasons?
      I. rapid onset of action
      II. smaller dosage used
      III. reduced side effects
      IV. drug is delivered to target organ
      V. safe and painless routeA. III and IV only
      B. I, III, and V only
      C. I, II, III, IV, and V
      D. I and II only

 

    1. Continuous nebulization of inhaled B agonists has been used for:
      A. pneumonia
      B. cystic fibrosis
      C. emphysema
      D. severe asthma

 

    1. The dosage recommended by NAEPP EPR 2 for continuous nebulization of adrenergic agents is:
      A. 8 to 12 mg/hr
      B. 10-15 mg/hr
      C. 20-30 mg/hr
      D. 5 to 8 mg/hr

 

    1. Your patient is receiving her third continuous nebulizer of albuterol (15 mg/hr). Which potential complications should you be on the look out for?
      I. hypokalemia
      II. cardiac arrhythmias
      III. hyperglycemia
      IV. PVCs
      V. tremorA. I, II, and V only
      B. I, II, IV, and V only
      C. I, II, III, IV, and IV
      D. II and IV only

 

    1. All of the following are side effects that should be monitored in you patient when using sympathomimetic aerosol except:
      A. muscle tremor
      B. bracycardia
      C. tachycardia
      D. insomnia

 

    1. You are ordered to extubate a mechanically ventilated patient who has recently undergone open heart surgery. On postextubation assessment you note that the patient has stridor with mild retractions. Pharmacologically, you would recommend:
      A. alpha adrenergic
      B. anticholinergic
      C. sympatholytic
      D. B2 adrenergic

 

    1. Which is the only B-agonist formulation that is a single isomer and is approved by the FDA for aerosol deliver?
      A. albuterol
      B. levalbuterol
      C. tiotropium
      D. epinephrine

 

    1. What is the rationale for using the single-isomer agent levalbuterol instead of racemic albuterol?
      A. the (S)-isomer is a weak bronchodilator
      B. The (R)-isomer is thought to cause tachycardia
      C. The (R)-isomer is thought to cause tremors
      D. the (S)-isomer is thought to promote bronchoconstriction

 

    1. What is the main difference between salmeterol and formoterol?
      A. formoterol has slower onset and peak effect compared with salmeterol
      B. formoterol is more B2 specific than salmeterol
      C. formoterol has a quicker onset and peak effect than salmeterol
      D. formoterol is a short-acting; salmeterol is long-acting

 

    1. What is the indication for use of a short-acing B agonist in asthma?
      A. rescue therapy in reversible airflow obstruction
      B. intiinflammatory agent in reversible airlow obstruction
      C. intiinfective agent in respiratory infections
      D. maintenance therapy in reversible airflow obstruction

 

    1. Is it appropriate to use formoterol as a rescue B-agonist bronchodilator?
      a. yes
      b. no
      • b. no
      • (because its a controller – up to 12 hours)

 

    1. Which procedure would tell you that a patient has reversible airway obstruction?
      A. pre- and postpulmonary function tests
      B. pulse oximetry
      C. wheezing on auscultation
      D. inspection: patient SOB when walking < 25 ft

 

    1. You receive an order to administer 5 ml of albuterol by SVN. You would:
      A. have your supervisor administer the treatment
      B. call the physician to confirm the medication dose
      C. give 0.5 ml of medication because that is probably what the doctor meant to write
      D. confirm the order on the char and administer as directed

 

    1. You are administering an aerosolized bronchodilator to your patient. Her pretreatment pulse was 85 bpm. You would stop the treatment if her pulse reached:
      A. 100
      B. 110
      C. 120
      D. 90

 

    1. A 7-yr-old boy has been given multiple aerosolized albuterol treatments over the last several days. You enter the room and his father tells you that every time a therapist administers a treatment, a few minutes later the saturation falls. You explain to the father:
      A. that this is abnormal and you will try to changle the med to levalbuterol
      B. that this is normal because of incr perfusion to poorly ventilated areas
      C. that this is abnormal and call the physician
      c. that this is normal because you are giving the treatment with air

 

    1. A patient with glottic edema is in mild distress. Which of the following medications would be of benefit in this situation?
      A. ipratropium bromide
      B. racemic epinephrine
      C. theophylline
      D. albuterol

 

    1. The only anticholinergic that is approved by the FDA for aerosolization is:
      A. albuterol sulfate
      B. glycopyrrolate
      C. atropine
      D. ipratropium bromide

 

    1. Ipratropium bromide can be delivered by which of the following methods?
      I. tablet
      II. nebulizer
      III. injection
      IV. MDI
      V. nasal sprayA. I, III, and IV only
      B. I, II, and IV only
      C. II, IV, and V only
      D. II only

 

    1. Atrovent is approved for:
      A. thinning of dried secretions
      B. acute bronchoconstriction
      C. maintenance treatment of airflow obstruction in COPD
      D. exacerbation of COPD

 

    1. Combivent is a combination drug including which agents?
      A. serevent and atrovent
      B. albuterol and atrovent
      C. maxair and atrovent
      D. albuterol and serevent

 

    1. Cholinergic stimulation will produce which of the following effects?
      I. bronchoconstrictionn
      II. incr mucus secretion
      III. miosis
      IV. decr heart rate
      V. salivationA. I, III, and V only
      B. II, III, and IV only
      C. I, II, III, IV, and V
      D. IV only

 

    1. Mucociliary slowing, bronchodilation, and increased heart rate are all a result of:
      A. adrenergic agents
      B. anticholinergic agents
      C. parasympathetic agents
      D. cholinergic agents

 

    1. Quaternary ammonium compounds such as ipratropium:
      A. do not cross lipid membranes easily
      B. are distributed quickly throught the body when inhaled
      C. have no role in respiratory care
      D. are not effective as inhaled agents

 

    1. Ipratropium agents may be indicated to treat:
      a. allergic rhinitis
      b. common cold
      c. nonallergic rhinitis
      d. all of the above

 

    1. Quaternary ammonium compounds cause bronchodilation by:
      A. stimulating cholinergic sites
      B. blocking adrenergic sites
      C. stimulating adrenergic sites
      D. blocking cholinergic sites


    1. Patients using ipratropium aerosols should be instructed to avoid allowing the aerosol in contact with their:
      A. nose
      B. eye
      C. ear
      D. hair

 

    1. Activating an atroven inhaler in the eye may cause:
      A. pupil dilation
      B. pupil constriction
      C. scarring of the cornea
      D. blindness

 

    1. Cardiac effects of aerosolized apratropium bromide include:
      A. incr blood pressure
      B. incr heart muscle contractility
      C. little or no effect
      D. incr heart rate

 

    1. Drugs that competitively block the action of acetylcholine at parasympathetic postganglionic effector cell receptors are called:
      A. adrenergic agents
      B. antimuscarinic agents
      C. cholinergic agents
      D. musarinic agents

 

    1. The most common side effect of anticholinergic bronchodilators is:
      A. incr heart rate
      B. wheezing
      C. delirium
      D. dry mouth

 

    1. Possible side effects of aerosolized atrovent include which of the following?
      I. flulike symptoms
      II. pharyngitits
      III. cardiac arrest
      IV. dry mouth
      V. dyspneaA. I, II, and IV only
      B. I, II, IV, and V only
      C. I, II, III, IV, and V
      D. I, II, and III only

 

    1. Results of your patient’s PFT show that the peak flow rate increased the most when she inhaled an aerosolized sympathomimetic agent and an aerosolized parasympatholytic agent. You would recommend that she be given:
      A. serevent DPI
      B. combivent MDI
      C. foradil DPI
      D. ventolin MDI

 

    1. What is the only once-a-day anticholinergic on the market?
      A. ipratropium bromide
      B. glycopyrrolate
      C. tiotropium bromide
      D. atropine

 

  1.  All of the following are true about piratropium, except:
    A. It can be combined with a B-agonist for maintenance bronchodilation in COPD.
    B. It is added to B-agonist in severe asthma episodes that do not respond to B-agonists alone.
    C. It is a leukotriene modifier used to treat step 3 asthma.
    D. It is a first-line choice of bronchodilator for COPD.
    1.Anticholinergic bronchodilator: An agent that BLOCKS parasympathetic nervous fibers, which allow RELAXATION of AIRWAY SMOOTH MUSCLE.

     

    2.Anticholinergic Effects: Increased Heart Rate
    Mydriasis (pupil dilation)
    Cycloplegia (lens flattening)
    Drying of upper airways
    Inhibition of tear formation
    Urinary retention
    Antidiarrheal or constipation
    Mucociliary slowing
    Inhibition of constriction

     

    3.Antimuscarinic bronchodilator: SAME as anticholinergic bronchodilator: an agent that BLOCKS the effect of acetylcholine at the cholinergic site

     

    4.Cholinergic: An agent that produces the effect of acetylcholine.

     

    5.Cholinergic Effects: Decreased Heart Rate
    Miosis (contraction of the iris)
    Contraction (thickening) of the lens
    Salivation
    Lacrimation
    Urination
    Defecation
    Secretion of mucus
    Bronchoconstriction

     

    6.Methacholine – What is the PRIMARY use of this cholinergic agent?: The PRIMARY clinical use of methacholine is to diagnose bronchial hyperreactivity (Methacholine challenge) which is the hallmark of asthma and also occurs in chronic obstructive pulmonary disease.

     

    7.Muscarinic: Same as cholinergic: an agent that produces the effect of acetylcholine or an agent that mimics acetylcholine

     

    8.Parasympatholytic: Blocking parasympathetic nervous fibers

     

    9.Parasympathomimetic: Producing effects SIMILAR to those of the parasympathetic nervous system

     

    10.Quarternary Compounds: Atropine Methylnitrate
    Ipratropium Bromide
    Tiotropium Bromide

     

    11.T/F – ANTICHOLINERGIC aerosols are found to be MORE potent bronchodilators that Beta adrenergic bronchodilators in BRONCHITIS and EMPHYSEMA (COPD).: TRUE – ANTICHOLINERGIC aerosols are found to be MORE potent bronchodilators that Beta adrenergic bronchodilators in BRONCHITIS and EMPHYSEMA (COPD).

     

    12.T/F – COMBIVENT is the brand name for a COMBINATION of Ipratroprium bromide AND Albuterol. In MDI form.: TRUE – COMBIVENT IS a combination of Iprtroprium bromide and Albuterol in MDI form with an onset of 15 mins, peaks at 1-2 hours and lasts 4 – 6 hours. Known as DUONEB in SVN/HHN form.

     

    13.T/F – Ipratroprium (Atrovent) and Tiotropium (Spiriva) ARE indicated as anticholinergic bronchodilators for patients receiving REGULAR treatment (Tx) COPD..: TRUE, both Ipratropium (Atrovent) and Tiotroprium (Spiriva) are anticholinergic bronchodilators that are indicated for Pts receivining REGULAR treatment (Tx) for COPD.

     

    14.T/F – Quaternary compounds like IPRATROPRIUM have side effects that are more LOCALIZED than TERTIARY compounds.: TRUE – Quaternary compounds like IPRATROPRIUM have side effects that are more LOCALIZED than TERTIARY compounds.

     

    15.T/F – Tioptrprium bromide is also known as SPIRIVA and has a duration of 12 hours.: FALSE – Tiotroprium bromide IS known as SPIRIVA BUT has a duration of 24 hours. It’s ONSET is 30 minutes and peaks in 1 – 3 hours.

     

    16.T/F Anticholinergic bronchodilators are STRICTLY parasympolytic, BLOCKING the effect of ACETYLCHOLINE at the CHOLINERGIC RECEPTORS on BRONCHIAL SMOOTH MUSCLE.: TRUE – Anticholinergic bronchodilators are STRICTLY parasympolytic, BLOCKING the effect of ACETYLCHOLINE at the CHOLINERGIC RECEPTORS on BRONCHIAL SMOOTH MUSCLE.

     

    17.Tertiary Compounds: Atropine
    Scopalamine

     

    18.Why would, THEORETICALLY, the combination of Beta adrenergic and Anticholinergic agents offer advantages in the Tx of COPD and asthma?: The combination of Beta adrenergic and antichlinergic agents offer advantages in the Tx of COPD and asthma because:
    A – Complimentary sites of action – Beta adrenergic smaller, more PERIPHERAL AW’s while the anticholinergic s more CENTRAL AW’s.
    B – The MECHANISMS of action are SEPARATE and COMPLIMENTARY.